NYSE:PEAK - New York Stock Exchange, Inc. - US42250P1030 - REIT - Currency: USD
17.1
+0.35 (+2.09%)
The current stock price of PEAK is 17.1 USD. In the past month the price decreased by -9.14%. In the past year, price decreased by -29.57%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
WELL | WELLTOWER INC | 92.85 | 105.65B | ||
VTR | VENTAS INC | 201.39 | 30.00B | ||
ARE | ALEXANDRIA REAL ESTATE EQUIT | N/A | 14.22B | ||
DOC | HEALTHPEAK PROPERTIES INC | 44 | 12.23B | ||
OHI | OMEGA HEALTHCARE INVESTORS | 23.28 | 11.32B | ||
CTRE | CARETRUST REIT INC | 32.91 | 5.99B | ||
AHR | AMERICAN HEALTHCARE REIT INC | N/A | 5.96B | ||
HR | HEALTHCARE REALTY TRUST INC | N/A | 5.66B | ||
SBRA | SABRA HEALTH CARE REIT INC | 30.88 | 4.34B | ||
DHCNL | DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 | N/A | 4.02B | ||
DHCNI | DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 | N/A | 3.82B | ||
NHI | NATL HEALTH INVESTORS INC | 23.62 | 3.32B |
Healthpeak Properties, Inc. is a real estate investment trust, which engages in the acquisition, development, ownership, and management of healthcare real estate. The company is headquartered in Denver, Colorado and currently employs 199 full-time employees. The firm acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in a diversified portfolio of high-quality healthcare properties across three core asset classes of life science, medical office, and continuing care retirement community (CCRC) real estate. The Company’s segments include Life science, Medical office, and CCRC. The Life Science segment properties contain laboratory and office space, which is leased primarily to biotechnology, medical device, and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The firm's Medical Office segment includes medical office buildings (MOBs) and hospitals. MOBs typically contain physicians’ offices and examination rooms and may also include pharmacies, hospital ancillary service space, and outpatient services.
HEALTHPEAK PROPERTIES INC
4600 South Syracuse Street, Suite 500
Denver COLORADO 80237 US
CEO: Thomas M. Herzog
Employees: 199
Phone: 19494070700
The current stock price of PEAK is 17.1 USD. The price increased by 2.09% in the last trading session.
The exchange symbol of HEALTHPEAK PROPERTIES INC is PEAK and it is listed on the New York Stock Exchange, Inc. exchange.
PEAK stock is listed on the New York Stock Exchange, Inc. exchange.
22 analysts have analysed PEAK and the average price target is 22.19 USD. This implies a price increase of 29.74% is expected in the next year compared to the current price of 17.1. Check the HEALTHPEAK PROPERTIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
HEALTHPEAK PROPERTIES INC (PEAK) has a market capitalization of 9.36B USD. This makes PEAK a Mid Cap stock.
HEALTHPEAK PROPERTIES INC (PEAK) currently has 199 employees.
HEALTHPEAK PROPERTIES INC (PEAK) has a support level at 16.37 and a resistance level at 17.11. Check the full technical report for a detailed analysis of PEAK support and resistance levels.
The Revenue of HEALTHPEAK PROPERTIES INC (PEAK) is expected to grow by 15.38% in the next year. Check the estimates tab for more information on the PEAK EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HEALTHPEAK PROPERTIES INC (PEAK) has a dividend yield of 7.02%. The yearly dividend amount is currently 1.2. Check the full fundamental report for a detailed analysis of PEAK dividend history, reliability and sustainability.
The PE ratio for HEALTHPEAK PROPERTIES INC (PEAK) is 30.54. This is based on the reported non-GAAP earnings per share of 0.56 and the current share price of 17.1 USD. Check the full fundamental report for a full analysis of the valuation metrics for PEAK.
ChartMill assigns a fundamental rating of 3 / 10 to PEAK. While PEAK is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months PEAK reported a non-GAAP Earnings per Share(EPS) of 0.56. The EPS decreased by -38.86% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 13.95% | ||
ROA | 1.94% | ||
ROE | 4.79% | ||
Debt/Equity | 1.08 |
ChartMill assigns a Buy % Consensus number of 78% to PEAK. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of -30.18% and a revenue growth 15.38% for PEAK